Dual Selective Serotonin Reuptake Inhibitor and Partial 5-HT1A Agonist (Binghamton University)

N/A

Report date: 2025/01/26 18:40:09
NME

Base Information

Drug NameDual Selective Serotonin Reuptake Inhibitor and Partial 5-HT1A Agonist (Binghamton University)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin reuptake inhibitorsSerotonin 1a (5-HT1a) receptor agonists
TargetsSerotonin transporterSerotonin 1a (5-HT1a) receptor
Therapy Area/IndicationsDyskinesias
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBinghamton University
China Registration ClassN/A

Develop Information

Active CompaniesBinghamton University
Inactive CompaniesN/A
Active IndicationsDyskinesias
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A